Colgate-Palmolive Company $CL Stock Position Lowered by Andra AP fonden

Andra AP fonden reduced its position in shares of Colgate-Palmolive Company (NYSE:CL) by 5.5% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 237,585 shares of the company’s stock after selling 13,800 shares during the period. Andra AP fonden’s holdings in Colgate-Palmolive were worth $18,993,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently bought and sold shares of CL. Westside Investment Management Inc. grew its stake in shares of Colgate-Palmolive by 85.5% in the 2nd quarter. Westside Investment Management Inc. now owns 282 shares of the company’s stock worth $26,000 after purchasing an additional 130 shares during the last quarter. Copia Wealth Management acquired a new position in Colgate-Palmolive in the third quarter worth approximately $29,000. Vermillion & White Wealth Management Group LLC increased its holdings in shares of Colgate-Palmolive by 86.1% in the second quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company’s stock valued at $30,000 after buying an additional 155 shares in the last quarter. Cloud Capital Management LLC acquired a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at $30,000. Finally, MTM Investment Management LLC bought a new stake in shares of Colgate-Palmolive during the 2nd quarter worth $39,000. 80.41% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, COO Panagiotis Tsourapas sold 15,000 shares of the company’s stock in a transaction dated Thursday, February 12th. The stock was sold at an average price of $97.81, for a total transaction of $1,467,150.00. Following the completion of the sale, the chief operating officer owned 10,415 shares in the company, valued at approximately $1,018,691.15. This represents a 59.02% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Sally Massey sold 15,851 shares of the firm’s stock in a transaction that occurred on Thursday, February 5th. The shares were sold at an average price of $95.03, for a total value of $1,506,320.53. Following the completion of the transaction, the insider directly owned 13,751 shares in the company, valued at $1,306,757.53. The trade was a 53.55% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 184,683 shares of company stock worth $17,486,693 over the last ninety days. 0.34% of the stock is currently owned by corporate insiders.

Colgate-Palmolive Trading Up 1.5%

NYSE:CL opened at $99.01 on Friday. The company has a market capitalization of $79.81 billion, a P/E ratio of 37.79, a P/E/G ratio of 4.40 and a beta of 0.29. The stock’s 50 day moving average price is $87.49 and its 200 day moving average price is $82.73. The company has a debt-to-equity ratio of 18.82, a quick ratio of 0.27 and a current ratio of 0.83. Colgate-Palmolive Company has a 52 week low of $74.54 and a 52 week high of $100.18.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The firm had revenue of $5.23 billion during the quarter, compared to analysts’ expectations of $5.13 billion. During the same period in the previous year, the company earned $0.91 earnings per share. The company’s revenue was up 5.8% compared to the same quarter last year. On average, research analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, February 13th. Shareholders of record on Wednesday, January 21st were given a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a yield of 2.1%. The ex-dividend date of this dividend was Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio is presently 79.39%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on CL shares. Royal Bank Of Canada raised Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 target price on the stock in a research report on Tuesday, December 9th. Deutsche Bank Aktiengesellschaft boosted their price objective on Colgate-Palmolive from $83.00 to $90.00 and gave the stock a “hold” rating in a report on Monday, February 2nd. Piper Sandler raised their target price on shares of Colgate-Palmolive from $88.00 to $96.00 and gave the stock an “overweight” rating in a report on Friday, January 30th. Rothschild & Co Redburn set a $93.00 target price on shares of Colgate-Palmolive in a research report on Friday, February 13th. Finally, Jefferies Financial Group upped their price target on shares of Colgate-Palmolive from $85.00 to $91.00 and gave the company a “hold” rating in a research report on Monday, February 2nd. Eleven research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, Colgate-Palmolive presently has an average rating of “Moderate Buy” and an average target price of $94.75.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.